about
Role of microRNAs in endothelial cell pathophysiologyEffects of nanoporous anodic titanium oxide on human adipose derived stem cells[Humanin and its derivatives as peptides with potential antiapoptotic and confirmed neuroprotective activities].A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome.Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties.Analysis of candidate genes in Polish families with obesity.Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell lines.Nutrient-gene interactions in benefit-risk analysis.Prevalence of Retinopathy in Adult Patients with GCK-MODY and HNF1A-MODY.Plasma centrifugation does not influence thrombin-antithrombin and plasmin-antiplasmin levels but determines platelet microparticles count.[Lp(a)--the current state of knowledge and clinical significance]The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity.An analysis of the link between polymorphisms of the beta2 and beta3 adrenergic receptor gene and metabolic parameters among Polish Caucasians with familial obesity.The microarray expression analysis identifies BAX as a mediator of beta-carotene effects on apoptosis.Association of single nucleotide polymorphism rs7579169 with hypertension disorders during pregnancy and perinatal outcome.Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice.Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study.Effect of caloric restriction on liver function in young and old ApoE/LDLr-/- miceDexamethasone inhibits TNF-alpha synthesis more effectively in Alzheimer's disease patients than in healthy individuals.Genetic Aspects of Obesity.DNA methylation in obesityNutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health[Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. I. Effect on cholesterol, lipid and apoprotein levels]Glycine and serine rich peptides isolated from rat liver preparations enriched with smooth endoplasmic membranesInteraction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg)Heterogeneity of high-density lipoprotein particles and insulin output during oral glucose tolerance test in men with coronary artery diseaseInfluence of SIN-1 and sodium nitroprusside (NANP) on ox-LDL metabolism in macrophages[Decrease in the level of free cholesterol fraction HDL as a risk factor for threatened atherosclerosis in idiopathic hyperinsulinemia]Modulation of LDL catabolism by sodium nitroprusside and PGE2 in human peripheral blood lymphocytesExpression of beta-galactosidase gene and endothelial nitric oxide synthase gene in rat vascular smooth muscle cells after in vitro lipotransfectionOxidized low density lipoprotein inhibits inducible nitric oxide synthase, GTP cyclohydrolase I and transforming growth factor beta gene expression in rat macrophagesNitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells[The importance of nitric oxide (NO) in the development of Helicobacter pylori infection][Is atherosclerosis an autoimmunological process?]Induction of nitric oxide synthase (NOS) and vascular endothelial growth factor (VEGF) in experimental model of angioplasty and heart ischemiaEvaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)[Nutrigenomics--about genetics and nutrition]Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation[Variants of adiponectin gene as risk factors for the metabolic syndrome]
P50
Q27011545-5D669966-60D7-4A4D-9125-3846C6A185D2Q28821452-1E00AEC4-C76C-4554-B496-D1ED4B032A70Q34225482-08726676-BFC2-4D87-B32E-59A090D6FFCEQ36302471-8B44F6F1-96E6-4348-BB5C-B5EE98E4AB73Q37811703-17B2625B-4178-4483-9330-1120BCEF0D1DQ38339982-F00F7F1D-29BC-4F60-8880-C2BA4A7B45D8Q39095859-A4F7DEF8-74C2-4180-BE36-A3A7486E3492Q40317087-4E1B8A79-9A37-4F61-B03B-1D705F9211C3Q41516228-B37625F5-8BDD-461F-95C7-D56B7B5EB45FQ42428015-FFF06170-A6EB-4137-90DF-C27CEDD7F43AQ43542132-DC100667-31F1-4660-866F-B9435002BF02Q44441370-98AEB4AF-0ADC-4F16-B5F3-5B44C276A1F7Q44490367-D6E1EC36-A067-431E-9B9E-CB3F89715B28Q46462880-2ABFBA2A-88B8-4FC5-91F8-BC61F29DD233Q48020047-DE385C32-1270-4BFF-9097-4068699BFCF2Q50953166-99BA23FF-A38C-4CA3-8565-2C6B9BD42DA2Q51385745-9F099D00-9CD2-4707-A531-DCEA811EF2C5Q51743015-85EF1B9F-F2A8-4C63-B56F-BF094F94AAD0Q53257572-3B370B67-E576-4754-8247-1953FF0AD612Q54963578-9E183220-D2DA-4F09-98BE-2B164D8388E8Q59632154-6D041B82-B109-4AD7-8DE1-D44A353B52FBQ61316669-4935F7D6-3A27-45DD-8A25-F99B9154EDD4Q70274118-EC66D718-083F-47F7-88B2-BFD5D740734CQ70444940-E221BC90-55EF-49AF-B179-1FBD2ED1BF69Q70550501-54F27082-D6EF-41D6-B828-0EEBC7F17764Q71455847-3CE31E9D-24D9-4D93-8509-9A61C7BF7B6AQ72498424-58DC9D21-B2B3-4AC0-8D5E-3549DBEE4859Q72726865-0D51905A-9820-4795-B9C2-D1007A931F4CQ72776999-9C8A23B2-819E-4842-A53E-47179256D020Q73101734-B6BF41B1-4E64-42B7-91F9-A20AB153F17CQ73210992-E9680075-7C0E-4393-A5AC-288AE7153740Q73500884-09BA674A-3AF3-455F-AF55-8FD301CB6F84Q73736864-345A2BAE-C835-46DD-9905-1CD0D7A90F78Q74215166-91D05688-358D-4E0E-94D2-975F83328949Q74483701-EDEEFAD4-DDF6-41A9-8D8C-DD8DE2D02577Q80626001-FEEA0385-778B-4960-9EFD-AD59025F1762Q81360103-D3DB35DE-F1E5-4400-BDD6-788D5B9E9917Q83393028-C7E69685-ACED-431F-9D96-ABF5423E6425Q84532732-6FB60C57-A2C8-4561-B347-0A6F76875057
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7421-7005
@en
name
I Wybranska
@ast
I Wybranska
@en
I Wybranska
@nl
type
label
I Wybranska
@ast
I Wybranska
@en
I Wybranska
@nl
prefLabel
I Wybranska
@ast
I Wybranska
@en
I Wybranska
@nl
P106
P31
P496
0000-0002-7421-7005